We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Idarubicin hydrochloride injection , USP 10mg/10mL vial (West-ward/ Hikma)
Section 19A approved medicine
(Approval lapsed) Idarubicin hydrochloride injection , USP 10mg/10mL vial (West-ward/ Hikma)
Section 19A approval holder
Orspec Pharma Pty Ltd ABN 15 634 980 417
Phone
02 4339 4239
Approved until
Status
Expired
Medicines in short supply/unavailable
ZAVEDOS idarubicin hydrochloride 10mg/10mL injection vial AUST R: 67398
Indication(s)
Idarubicin Hydrochloride injection, USP in combination with other approved antileukemic drugs is indicated for the treatment of acute myeloid leukemia (AML) in adults.
Images
